Treatment options for locally advanced breast cancer - experience in an Asian tertiary hospital

Asian Pacific Journal of Cancer Prevention

Volumn 11, Issue 4, 2010, Pages 913-917

  Chong, Hoong Yin ^a   Taib, Nur Aishah ^a   Rampal, Sanjay ^b   Saad, Marniza ^c   Bustam, Anita Zarina ^c   Yip, Cheng Har ^a  

^a UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

^c Clinical Oncology Unitvers   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78650712593     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Agarwal G, Pradeep PV, Aggarwal V, et al (2007). Spectrum of breast cancer in Asian women. World J Surg, 31, 1031-40.
2. Carter CL, Allen C, Henson DE. (1989). Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer, 63, 181-7.
3. Fisher B, Bryant J, Wolmark N, et al (1998). Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol, 16, 2672-85.
4. Lim G, Chye CHY, Ministry of Health (2003). 2nd report of the national cancer registry, cancer incidence in Malaysia.
5. Giordano SH. (2003). Update on locally advanced breast cancer. Oncologist, 8, 521-30.
6. Hisham AN, CH Yip. (2003). Spectrum of breast cancer in Malaysian women: overview. World J Surg, 27, 921-3.
7. Leong BD, Chuah JA, Kumar VM, et al (2007). Breast cancer in Sabah, Malaysia: a two year prospective study. Asian Pac J Cancer Prev, 8, 525-9.
8. Makris A, Powles TJ, Ashley SE, et al (1998). A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer. Ann Oncol, 9, 1179-84.
9. Mamounas EP. (1997). NSABP Protocol B-27. Preoperative doxorubicin plus cyclophosphamide followed by preoperative or postoperative docetaxel. Oncology, 11, 37-40.
10. Mohd Taib NA, Yip CH, Mohamed I. (2008). Survival analysis of Malaysian women with breast cancer: results from the University of Malaya Medical Centre. Asian Pac J Cancer Prev, 9, 197-202.
11. Norsa'adah B, Rusli BN, Imran AK, et al (2005). Risk factors of breast cancer in women in Kelantan, Malaysia. Singapore Med J, 46, 698-705.
12. Paley PJ. (2001). Screening for the major malignancies affecting women: current guidelines. Am J Obstet Gynecol, 184, 1021-30.
13. Singletary SE, Allred C, Ashley P, et al (2002). Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol, 20, 3628-36.
14. Tan EY, Wong HB, Ang BK, et al (2005). Locally advanced and metastatic breast cancer in a tertiary hospital. Ann Acad Med Singapore, 34, 595-601.
15. Toonkel LM, Fix I, Jacobson LH, et al (1986). Locally advanced breast carcinoma: results with combined regional therapy. Int J Radiat Oncol Biol Phys, 12, 1583-7.
16. Valagussa P, M Zambetti, et al (1983). T3b-T4 breast cancer: factors affecting results in combined modality treatments. Clin Exp Metastasis, 1, 191-202.
17. Valagussa P, Zambetti M, Bignami P, et al (2001). Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902. J Clin Oncol, 19, 4224-37.
18. Wolff AC, NE Davidson. (2002). Preoperative therapy in breast cancer: lessons from the treatment of locally advanced disease. Oncologist, 7, 239-45.
19. Yip CH, Taib NA, Mohamed I. (2006). Epidemiology of breast cancer in Malaysia. Asian Pac J Cancer Prev, 7, 369-74.